Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)
China flag China · Delayed Price · Currency is CNY
59.23
+2.52 (4.44%)
Mar 9, 2026, 3:00 PM CST

SHA:688580 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
462.73395.34455.44319.67428.73
Other Revenue
-4.726.781.951.31
462.73400.06462.22321.62430.04
Revenue Growth (YoY)
15.66%-13.45%43.72%-25.21%13.66%
Cost of Revenue
-138.26149.1688.52108.45
Gross Profit
462.73261.8313.06233.1321.59
Selling, General & Admin
-138.92152.48129.71116.08
Research & Development
-50.6157.6543.7363.52
Other Operating Expenses
312.16-11.64-14.08-7.67-6.97
Operating Expenses
312.16179.33198.31166.29173.52
Operating Income
150.5682.48114.7566.82148.07
Interest Expense
--1.31-1.32-0.33-0.18
Interest & Investment Income
-21.1129.935.2937.35
Other Non Operating Income (Expenses)
2.110.140.06-0.2-0.04
EBT Excluding Unusual Items
152.67102.42143.39101.57185.2
Gain (Loss) on Sale of Investments
-2.42-0.96--
Gain (Loss) on Sale of Assets
--0.01-0.01-0.01-0.01
Other Unusual Items
-8.457.64.2912.19
Pretax Income
152.67113.28150.01105.84197.38
Income Tax Expense
16.0411.3113.7512.0119.84
Earnings From Continuing Operations
136.63101.97136.2693.83177.54
Minority Interest in Earnings
----0.28
Net Income
136.63101.97136.2693.83177.81
Net Income to Common
136.63101.97136.2693.83177.81
Net Income Growth
33.99%-25.16%45.23%-47.23%23.77%
Shares Outstanding (Basic)
9695969696
Shares Outstanding (Diluted)
9695969696
Shares Change (YoY)
0.12%-0.29%0.05%-0.31%17.41%
EPS (Basic)
1.431.071.430.981.86
EPS (Diluted)
1.431.071.420.981.85
EPS Growth
33.83%-24.95%45.16%-47.07%5.42%
Free Cash Flow
-5.210.72-9.4570.02
Free Cash Flow Per Share
-0.060.01-0.100.73
Dividend Per Share
-0.8001.0760.4910.930
Dividend Growth
--25.62%119.02%-47.19%23.87%
Gross Margin
100.00%65.44%67.73%72.48%74.78%
Operating Margin
32.54%20.62%24.82%20.77%34.43%
Profit Margin
29.53%25.49%29.48%29.17%41.35%
Free Cash Flow Margin
-1.30%0.15%-2.94%16.28%
EBITDA
170.65102.56133.6982.77157.96
EBITDA Margin
36.88%25.64%28.92%25.74%36.73%
D&A For EBITDA
20.0920.0918.9515.959.89
EBIT
150.5682.48114.7566.82148.07
EBIT Margin
32.54%20.62%24.82%20.77%34.43%
Effective Tax Rate
10.51%9.98%9.17%11.35%10.05%
Revenue as Reported
-400.06462.22321.62430.04
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.